Quick Answer
Resveratrol Supplementation Cardiometabolic Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: This review was based on a narrative literature search designed to identify experimental, clinical, and translational evidence linking natural products with gut barrier integrity, gut microbiota, low-grade inflammation, and metabolic endotoxemia.
Key Takeaways
- 01This review was based on a narrative literature search designed to identify experimental, clinical, and translational evidence linking natural products with gut barrier integrity, gut microbiota, low-grade inflammation, and metabolic endotoxemia. [Šantić Roko (2026)]
- 02Because this article is a narrative review rather than a systematic review, formal risk-of-bias assessment and quantitative evidence synthesis were not performed. [Šantić Roko (2026)]
- 03Over the past two decades, accumulating evidence has repositioned the gastrointestinal tract from a passive absorptive organ to an immunologically active barrier whose functional state directly influences systemic inflammatory tone and metabolic homeostasis []. [Šantić Roko (2026)]
- 04Reference lists of relevant reviews and primary studies were additionally screened to identify articles not captured by database searches. [Šantić Roko (2026)]
The current Migaku evidence database contains 1 reusable source document for Resveratrol Supplementation Cardiometabolic Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation.
- This review was based on a narrative literature search designed to identify experimental, clinical, and translational evidence linking natural products with gut barrier integrity, gut microbiota, low-grade inflammation, and metabolic endotoxemia. [Šantić Roko (2026); evidence level 3]
- Because this article is a narrative review rather than a systematic review, formal risk-of-bias assessment and quantitative evidence synthesis were not performed. [Šantić Roko (2026); evidence level 3]
- Over the past two decades, accumulating evidence has repositioned the gastrointestinal tract from a passive absorptive organ to an immunologically active barrier whose functional state directly influences systemic inflammatory tone and metabolic homeostasis []. [Šantić Roko (2026); evidence level 3]
- Reference lists of relevant reviews and primary studies were additionally screened to identify articles not captured by database searches. [Šantić Roko (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources